Evaluation of triamcinolone acetonide following intravitreal injection in New Zealand white rabbits

International Journal of Toxicology

Volumn 24, Issue 6, 2005, Pages 419-425

  McGee, David H ^a   Dembinska, Olga ^a   Gruebbel, Margarita M ^b  

^a ALCON RESEARCH LTD   (United States)

^b EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

Author keywords

Corticosteroid; Intraocular; Intravitreal; Ophthalmic; Rabbits; Retina; Toxicity; Triamcinolone Acetonide

Indexed keywords

BALANCED SALT SOLUTION; BUFFER; DRUG VEHICLE; POLYMER; TOBRAMYCIN; TRIAMCINOLONE ACETONIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOPHIL; BODY WEIGHT; BODY WEIGHT DISORDER; CATARACT; CONTROLLED STUDY; CORNEA THICKNESS; DRUG ACCUMULATION; DRUG FORMULATION; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; ELECTRORETINOGRAM; EYE; FEMALE; HAIR LOSS; HISTOPATHOLOGY; INFECTION; INFECTION PREVENTION; INJECTION; INTRAOCULAR HYPOTENSION; LENS DISEASE; LIFE; MALE; MATERIALS; NEW ZEALAND; NONHUMAN; OBSERVATION; OPHTHALMOSCOPY; RABBIT; READING; RETINA; SCRATCHING; SKIN BRUISING; SLIT LAMP; STATISTICAL SIGNIFICANCE; SURFACE PROPERTY; SUSPENSION; TISSUE STRUCTURE; WEIGHT CHANGE;

ANIMALS; BODY WEIGHT; CORNEA; DRUG EVALUATION, PRECLINICAL; FEMALE; GLUCOCORTICOIDS; INJECTIONS; INTRAOCULAR PRESSURE; MALE; RABBITS; RETINA; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 30344452583     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810500366864     Document Type: Article

References (17)

1. Bartlett, J., T. Wolley, and C. Adams. 1993. Identification of high intraocular pressure responders to topical ophthalmic corticosteroids. J. Ocul. Pharmacol. 9:35-45.
2. Burke, J. A., T. Lin, B. Jackson, K.-M. Zhang, W. Orilla, J. Yang, A. D. Kulkarni, R. Tzekov, B. D. Kuppermann, and L. Wheeler. 2004. The effects of intravitreal triamcinolone acetonide (TA) on collateral damage induced by verteporfin PDT in normal rabbits and cynomolgus monkeys. Abstract 1861, Poster no. B672. Invest. Ophthalmol. Vis. Sci. 45.
3. Carnbahan, M., and D. Goldstein. 2000. Ocular complications of topical, periocular and systemic corticosteroids. Curr. Opin. Ophthalmol. 11:478-483.
4. Grant, W. M., Toxicology of the eye. 1986. Springfield, IL: Charles C. Thomas Publisher.
5. Hackett, R. B., and T. O. McDonald. 1996. Assessing eye irritation. In Dermatotoxicology, ed. F. N. Marzulli and H. I. Maibach, 557-567. Washington, DC. Taylor and Francis.
6. Hida, T., D. Chandler, J. Arena, and R. Machemer. 1986. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroids preparations. Am. J. Ophthalmol. 101:190-195.
7. Jonas, J. B. I. Kreissig, A. Sofker, et al. 2003. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch. Ophthalmol. 121:57-61.
8. Lai, C.-C. W.-C. Wu, M.-H. Sun, L.-H. Chuang, and K. Lin. 2004. Suppression of experimental choroidal neovascularization by subretinal injection of triamcinolone acetonide. Abstract 471, Poster no. B444. Invest. Ophthalmol. Vis. Sci. 45.
9. McCuen, B., M. Bessler, Y. Tano, D. Chandler, and R. Machemer. 1981. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am. J. Ophthalmol. 91:785-787.
10. Morrison, V. L., H. J. Koh, L. Cheng, K. Bessho, and W. R. Freeman. 2004. Intravitreal toxicity of the KENALOG vehicle (benzyl alcohol) in rabbits. Abstract 1917, Poster No. B728. Invest. Ophthalmol. Vis. Sci. 45.
11. Moshfeghi, D., P. Kaiser, I. Scott, J. Sears, M. Benz, J. Sinesterra, R. Kaiser, S. I. Bakri, R. Maturi, J. Belmont, P. Beer, T. Murray, H. Quiroz-Mercado, and W. Mieler. 2003. Acute endophthalmitic following intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol. 136:791-796.
12. National Eye Institute, Eye injections of triamcinolone acetonide for retinal blood vessel disorders. http://www.Clinicaltrials.gov/ct/gui/show/ NCT00071227.
13. Perlman, I., E. Zemel, B. Miller, H. Gazozi, and Y. Lang. 2003. Retinal toxicity of intravitreal Kenalog in albino rabbits. Abstract 4899. Invest. Ophthalmol. Vis. Sci. 44.
14. Robinson, M. R., H. Kim, L. Gravlin, G. Tansey, G. Grimes, G. Potti, P. Yuan, and K. G. Csaky. 2004. Preclinical evaluation of a triamcinolone acetonide preservative free (TAC-PF) formulation for intravitreal injection. Abstract 5058, Poster no. B382. Invest. Ophthalmol. Vis. Sci. 45.
15. Sung, E., W. Alward, J. Folk, Y. Kwon, and D. Zumbro, 2004. Intraocular pressure elevation with injection of intravitreal triamcinolone acetonide. Resident /Fellow Research presentation, University of Iowa. http://webeye.ophtl. uiowa,edu/dept/RESFELO/resday2004/sung.htm.
16. Tu, A. H., R. Equi, S.-I. Arai, S. Sadda, S. Varner, N. Rao, and E. de Juan, Jr. 2004. Subretinal delivery of triamcinolone in a laser-induced primate model of choroidal neovascularization: Angiographic and histopathological study. Abstract 5055. Invest. Ophthalmol. Vis. Sci. 45.
17. Willis, M. C., R. Munger, G. Baskin, S. Bussa, and T. Hack. 2005. Intravitreal triamcinolone acetonide in cynomolgus monkeys: Results of a toxicity. Study. Abstract 490. Invest. Ophthalmol. Vis. Sci. 46.